Corpus Intelligence IC Memo — ADVENTIST HEALTH SONORA 2026-04-26 17:22 UTC
IC Memo — ADVENTIST HEALTH SONORA
Investment Committee Memorandum | CA | 84 beds | Grade C | EBITDA uplift $20.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ADVENTIST HEALTH SONORA

CCN 050335 | TUOLUMNE, CA | 84 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ADVENTIST HEALTH SONORA is a 84-bed suburban community hospital in TUOLUMNE, CA with $274.3M in net patient revenue and a -7.4% operating margin. The hospital serves a payer mix of 53.3% Medicare, 3.4% Medicaid, and 43.3% commercial.

Thesis: Turnaround. Our ML models identify $20.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -7.4% to -0.1% (+736bps).

Net Revenue HCRIS$274.3M
Current EBITDA COMPUTED$-20.4M
Operating Margin COMPUTED-7.4%
Occupancy HCRIS50.7%
Revenue / Bed COMPUTED$3.3M
Net-to-Gross HCRIS20.4%
Distress Probability ML44.7%

2. Market Context & Competitive Position

414
CA Hospitals
-4.9%
State Median Margin
158
Comparable Hospitals

CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of -7.4% places it below the state median. Among 158 size-comparable peers (42-168 beds), the median margin is -4.6%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (42-168), prioritizing same-state peers. 158 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ADVENTIST HEALTH SONORA (Target)CA84$274.3M-7.4%
CHILDRENS HOSP & RES CNTR OAKLCA155$687.9M-7.1%
CONTRA COSTA REGIONAL MEDICAL CA124$595.0M-29.2%
RANCHO LOS AMIGOS NATL.REHAB.CCA83$512.6M41.9%
USC NORRIS CANCER HOSPITALCA60$468.7M19.1%
KFH - ANTIOCHCA144$445.4M8.1%
KFH - VACAVILLECA144$415.3M7.1%
SCRIPPS GREEN HOSPITALCA150$403.2M14.2%
EDEN MEDICAL CENTERCA126$389.8M2.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $20.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$5.8M+210bp18mo
Cost to Collect4.5%2.5%$5.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$5.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$3.3M+122bp9mo
Clean Claim Rate88.0%96.0%$176K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$5.8M
Cost to Collect
$5.5M
Denial Rate Reduction
$5.4M
A/R Days Reduction
$3.3M
Clean Claim Rate
$176K
Total EBITDA Uplift$20.2M
Current EBITDA$-20.4M
+ RCM Uplift+$20.2M
Pro Forma EBITDA$-244K
Current Margin-7.4%
Pro Forma Margin-0.1%
WC Released (1x)$10.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-31.4M$67.1M0.00x-100.0%
Base (11x exit)10.0x11.0x$-31.4M$63.6M0.00x-100.0%
Bull Case9.0x11.0x$-28.3M$120.0M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-28.3M$122.6M0.00x-100.0%
Bear Case11.0x10.0x$-34.6M$-23.6M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-34.6M$-37.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 158 hospitals with 42-168 beds
  • Same-state prioritization (n=159)
  • Comp margins: P25=-21.6% / P50=-4.6% / P75=3.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.